तुलना करने के लिए मीट्रिक्स | ASBP | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधASBPपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −0.9x | −0.3x | −0.4x | |
PEG अनुपात | −0.01 | 0.04 | 0.00 | |
क़ीमत/बुक | 2.6x | 0.6x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 292.0x | 2.8x | 3.1x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 155.5% | 48.2% | |
उचित मूल्य अपसाइड | अनलॉक करें | 13.3% | 5.8% | अनलॉक करें |
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.